ATE539766T1 - Intranasale influenzaimpfstoffe aus virosomen - Google Patents

Intranasale influenzaimpfstoffe aus virosomen

Info

Publication number
ATE539766T1
ATE539766T1 AT09178084T AT09178084T ATE539766T1 AT E539766 T1 ATE539766 T1 AT E539766T1 AT 09178084 T AT09178084 T AT 09178084T AT 09178084 T AT09178084 T AT 09178084T AT E539766 T1 ATE539766 T1 AT E539766T1
Authority
AT
Austria
Prior art keywords
influency
virosomes
vaccines
intranasal
intranasal influency
Prior art date
Application number
AT09178084T
Other languages
English (en)
Inventor
Alexander J Kersten
Lisya Gerez
Pieter J Schoen
Jozef J P Nauta
Rheineck Leyssius Dorine Van
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Application granted granted Critical
Publication of ATE539766T1 publication Critical patent/ATE539766T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT09178084T 2006-03-22 2007-03-21 Intranasale influenzaimpfstoffe aus virosomen ATE539766T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78446206P 2006-03-22 2006-03-22
EP06111534 2006-03-22

Publications (1)

Publication Number Publication Date
ATE539766T1 true ATE539766T1 (de) 2012-01-15

Family

ID=38038698

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07727166T ATE451931T1 (de) 2006-03-22 2007-03-21 Intranasale influenza-vakzine auf basis von virosomen
AT09178084T ATE539766T1 (de) 2006-03-22 2007-03-21 Intranasale influenzaimpfstoffe aus virosomen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07727166T ATE451931T1 (de) 2006-03-22 2007-03-21 Intranasale influenza-vakzine auf basis von virosomen

Country Status (21)

Country Link
EP (2) EP2158921B1 (de)
JP (1) JP5285595B2 (de)
KR (1) KR20090016659A (de)
AR (1) AR059972A1 (de)
AT (2) ATE451931T1 (de)
AU (1) AU2007228736B2 (de)
BR (1) BRPI0709864A2 (de)
CA (1) CA2646895A1 (de)
DE (1) DE602007003815D1 (de)
DK (2) DK1996229T3 (de)
EA (1) EA014532B1 (de)
ES (2) ES2338382T3 (de)
HR (2) HRP20100144T1 (de)
IL (1) IL193840A (de)
MY (1) MY142996A (de)
NO (1) NO20084452L (de)
PL (2) PL2158921T3 (de)
PT (2) PT2158921E (de)
SA (1) SA07280116B1 (de)
SI (2) SI1996229T1 (de)
WO (1) WO2007107585A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101707569B1 (ko) * 2008-08-01 2017-02-16 감마 백신즈 피티와이 리미티드 인플루엔자 백신
EA201300525A1 (ru) * 2010-11-02 2014-02-28 Гектор Мануэль Сепеда Лопес Новые вакцины против пандемичного вируса гриппа a/h1n1
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
EP1447080A1 (de) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Methode zur Herstellung von Virosomen-artigen Partikeln
TWI329130B (en) * 2003-06-19 2010-08-21 Bestewil Holding Bv Functionally reconstituted viral membranes containing adjuvant

Also Published As

Publication number Publication date
PT1996229E (pt) 2010-03-16
SI1996229T1 (sl) 2010-04-30
EP1996229B1 (de) 2009-12-16
HRP20120013T1 (hr) 2012-01-31
HRP20100144T1 (hr) 2010-04-30
EP2158921A1 (de) 2010-03-03
AR059972A1 (es) 2008-05-14
ATE451931T1 (de) 2010-01-15
EP2158921B1 (de) 2012-01-04
WO2007107585A1 (en) 2007-09-27
SI2158921T1 (sl) 2012-03-30
PT2158921E (pt) 2012-03-27
MY142996A (en) 2011-02-14
DE602007003815D1 (en) 2010-01-28
EA014532B1 (ru) 2010-12-30
DK1996229T3 (da) 2010-05-03
EA200870361A1 (ru) 2009-02-27
CA2646895A1 (en) 2007-09-27
EP1996229A1 (de) 2008-12-03
AU2007228736A1 (en) 2007-09-27
BRPI0709864A2 (pt) 2011-07-26
NO20084452L (no) 2008-10-22
JP5285595B2 (ja) 2013-09-11
ES2375436T8 (es) 2012-03-15
IL193840A0 (en) 2011-08-01
IL193840A (en) 2011-10-31
ES2338382T3 (es) 2010-05-06
SA07280116B1 (ar) 2010-10-19
PL1996229T3 (pl) 2010-05-31
DK2158921T3 (da) 2012-05-07
KR20090016659A (ko) 2009-02-17
PL2158921T3 (pl) 2012-06-29
AU2007228736B2 (en) 2011-12-15
ES2375436T3 (es) 2012-02-29
JP2009530351A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
ATE450271T1 (de) Impfstoff
DE602007009267D1 (de) Reifenaufblasverfahren
ATE546437T1 (de) Aminomethyl-4-imidazole
DE502007000218D1 (de) nsetzungen
DK2214640T3 (da) Intranasale sammensætninger
EP2049032A4 (de) Verbesserter impinger
FI20061014A0 (fi) Diffuusiopinnoitusmenetelmä
DE112007003147A5 (de) Rohr-Biegevorrichtung
DE602007012951D1 (de) Verbundschraubenausräumtür
DE502007005975D1 (de) Wischblatt
FI20060691A0 (fi) Laitekotelointi
ITPD20060387A1 (it) Espositore
DE112007001125A5 (de) Käfigmutter
DK2158921T3 (da) Intranasal influenzavaccine baseret på virosomer
ITMI20062042A1 (it) Elettrovalvola
NO20060756L (no) Transportsystem
SE0600253L (sv) Hållaranordning
FI20060398A0 (fi) Pellettipuristin
FR2896376B1 (fr) Desherbeuse-emietteuse
DE112007001450A5 (de) Verbessertes Surfrigg
ES1062366Y (es) Interruptor-seccionador aereo
SE0601081L (sv) Hållaranordning
ES1063205Y (es) Sabana encimera
ITFI20060258A1 (it) Vibro paradonto
ITMN20060046A1 (it) Aereo